Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T22:19:26.635Z.
Calculation as of: 2026-10-06T22:19:26.635Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: dc3fa1fa429e6ac4f0d7012b2af5cf8e78abb5153a19c38995711b2f102458f4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$438.07M
PS Ratio
N/A
TTM Avg
70.89
3Y Avg
76.22
5Y Avg
76.22
Market Cap
$442.34M
PS Ratio
279.43
TTM Avg
36.80
3Y Avg
225.33
5Y Avg
298.60
Market Cap
$426.51M
PS Ratio
3.65
TTM Avg
7.42
3Y Avg
11381.45
5Y Avg
7006.56
Market Cap
$445.71M
PS Ratio
N/A
TTM Avg
46.72
3Y Avg
25.82
5Y Avg
135.95
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| YD Bio Limited Ordinary Shares (YDES) | $435.61M | N/A | N/A | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $438.07M | N/A | 70.89 | 76.22 | 76.22 |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 4.37 | 5.09 | 4.43 | 3.92 |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.55M | 5.87 | 6.30 | 5.65 | 8.52 |
| Ovid Therapeutics Inc. (OVID)vs › | $442.34M | 279.43 | 36.80 | 225.33 | 298.60 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 3.65 | 7.42 | 11381.45 | 7006.56 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | N/A | 46.72 | 25.82 | 135.95 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 0.55 | 0.42 | 0.50 | 0.63 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 0.37 | 0.69 | 0.87 | 1.45 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
